[go: up one dir, main page]

KR950013513A - 약제 제조용 모에노마이신 및 이의 유도체, 및 모에노마이신 또는 이의 유도체를 함유하는 약제 - Google Patents

약제 제조용 모에노마이신 및 이의 유도체, 및 모에노마이신 또는 이의 유도체를 함유하는 약제 Download PDF

Info

Publication number
KR950013513A
KR950013513A KR1019940031633A KR19940031633A KR950013513A KR 950013513 A KR950013513 A KR 950013513A KR 1019940031633 A KR1019940031633 A KR 1019940031633A KR 19940031633 A KR19940031633 A KR 19940031633A KR 950013513 A KR950013513 A KR 950013513A
Authority
KR
South Korea
Prior art keywords
derivatives
moenomycin
medicament
manufacture
gastric ulcer
Prior art date
Application number
KR1019940031633A
Other languages
English (en)
Inventor
리쓰 귄터
사이베르트 게르하르트
헤트만 우도
Original Assignee
짜우너, 루츠
훽스트 아크티엔게젤샤프트
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 짜우너, 루츠, 훽스트 아크티엔게젤샤프트 filed Critical 짜우너, 루츠
Publication of KR950013513A publication Critical patent/KR950013513A/ko

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7028—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages
    • A61K31/7034—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages attached to a carbocyclic compound, e.g. phloridzin
    • A61K31/7036—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages attached to a carbocyclic compound, e.g. phloridzin having at least one amino group directly attached to the carbocyclic ring, e.g. streptomycin, gentamycin, amikacin, validamycin, fortimicins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2300/00—Mixtures or combinations of active ingredients, wherein at least one active ingredient is fully defined in groups A61K31/00 - A61K41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Molecular Biology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Saccharide Compounds (AREA)

Abstract

본 발명은 약제 제조용 모에노마이신 및 이의 유도체 및 모에노마이신 또는 이의 유도체를 함유하는 약제에 관한 것이다. 모에노마이신 및 이의 유도체는 위궤양의 치료 및 헬리코박터 필로리 감염증 치료용 약제 제조에 적합하다.

Description

약제 제조용 모에노마이신 및 이의 유도체, 및 모에노마이신 또는 이의 유도체를 함유하는 약제
본 내용은 요부공개 건이므로 전문내용을 수록하지 않았음

Claims (6)

  1. 위궤양의 치료 및 위암을 예방하기 위한 약제를 제조하기 위한 모에노마이신 및/또는 하나 이상의 이의 유도체의 용도.
  2. 헬리코박터 필로리 감염증 치료용 약제를 제조하기 위한 모에노마이신 및/또는 하나 이상의 이의 유도체의 용도.
  3. 모에노마이신 및/또는 하나 이상의 이의 유도체 이외에 추가로 하나 이상의 위궤양 치료제 및/또는 항생제를 함유하는 약제.
  4. 모에노마이신 및/또는 하나 이상의 이의 유도체를 하나 이상의 추가의 위궤양 치료제 및, 또는 항생제와 함께 및, 경우에 따라, 약리학적으로 허용되는 보조제 및/또는 부형제를 사용하여 적합한 투여형태로 제조함을 포함하여 제 3항에서 청구한 약제를 제조하는 방법.
  5. 위궤양의 치료 및/또는 위암의 예방을 위한 제 3항에서 청구한 약제의 용도.
  6. 제 3항에서 청구한 약제를 투여함을 포함하여 위궤양을 치료하는 방법
    ※ 참고사항 : 최초출원 내용에 의하여 공개하는 것임.
KR1019940031633A 1993-11-30 1994-11-29 약제 제조용 모에노마이신 및 이의 유도체, 및 모에노마이신 또는 이의 유도체를 함유하는 약제 KR950013513A (ko)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE4340774A DE4340774A1 (de) 1993-11-30 1993-11-30 Moenomycin und dessen Derivate zur Herstellung von Arzneimitteln, sowie Arzneimittel mit einem Gehalt an Moenomycin oder dessen Derivaten
DEP4340774.9 1993-11-30

Publications (1)

Publication Number Publication Date
KR950013513A true KR950013513A (ko) 1995-06-15

Family

ID=6503798

Family Applications (1)

Application Number Title Priority Date Filing Date
KR1019940031633A KR950013513A (ko) 1993-11-30 1994-11-29 약제 제조용 모에노마이신 및 이의 유도체, 및 모에노마이신 또는 이의 유도체를 함유하는 약제

Country Status (18)

Country Link
US (1) US6242424B1 (ko)
EP (1) EP0655249B1 (ko)
JP (1) JPH07188030A (ko)
KR (1) KR950013513A (ko)
CN (1) CN1108104A (ko)
AT (1) ATE199497T1 (ko)
AU (1) AU693482B2 (ko)
BR (1) BR9404781A (ko)
CA (1) CA2136936A1 (ko)
DE (2) DE4340774A1 (ko)
DK (1) DK0655249T3 (ko)
ES (1) ES2154665T3 (ko)
GR (1) GR3035928T3 (ko)
IL (1) IL111780A0 (ko)
NO (1) NO944575L (ko)
NZ (1) NZ270002A (ko)
PT (1) PT655249E (ko)
ZA (1) ZA949468B (ko)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE19709897A1 (de) * 1997-03-11 1998-09-17 Hoechst Ag Wismutsalze von Antibiotika der Moenomycin-Gruppe, Verfahren zu ihrer Herstellung, ihre Verwendung und solche Salze enthaltende Arzneimittel
US6114309A (en) 1997-11-21 2000-09-05 Incara Research Laboratories Combinatorial library of moenomycin analogs and methods of producing same
EP1069130B1 (en) * 1999-07-15 2004-08-11 Hoechst Marion Roussel Moenomycin A Derivatives, their preparation, and use as antibacterial products
US6585846B1 (en) 2000-11-22 2003-07-01 3M Innovative Properties Company Rotary converting apparatus and method for laminated products and packaging
WO2008021367A2 (en) * 2006-08-11 2008-02-21 President And Fellows Of Harvard College Moenomycin biosynthesis-related compositions and methods of use thereof
WO2009046314A2 (en) * 2007-10-04 2009-04-09 President And Fellows Of Harvard College Moenomycin analogs, methods of synthesis, and uses thereof
US8916540B2 (en) * 2008-01-15 2014-12-23 Academia Sinica Antibiotic compositions and related screening methods
US20100309510A1 (en) * 2009-06-09 2010-12-09 Accipiter Innovations, Llc Systems, methods and devices for printing from a mobile device
EP2850090B1 (en) 2012-04-06 2018-10-03 President and Fellows of Harvard College Chemoenzymatic methods for synthesizing moenomycin analogs
WO2013151697A1 (en) 2012-04-06 2013-10-10 President And Fellows Of Harvard College Methods and compounds for identifying glycosyltransferase inhibitors
WO2013152277A2 (en) 2012-04-06 2013-10-10 President And Fellows Of Harvard College Moenomycin analogs, methods of synthesis, and uses thereof
US11883421B2 (en) * 2017-05-05 2024-01-30 Huvepharma Functionalized saccharides as anti-inflammatory agents

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0130327B1 (de) * 1983-05-21 1987-11-04 Hoechst Aktiengesellschaft Moenomycin A-Derivate, Verfahren zu ihrer Herstellung und ihre Verwendung als Antibiotika

Also Published As

Publication number Publication date
IL111780A0 (en) 1995-01-24
GR3035928T3 (en) 2001-08-31
NO944575L (no) 1995-05-31
JPH07188030A (ja) 1995-07-25
AU693482B2 (en) 1998-07-02
NO944575D0 (no) 1994-11-29
CA2136936A1 (en) 1995-05-31
EP0655249B1 (de) 2001-03-07
ATE199497T1 (de) 2001-03-15
DE4340774A1 (de) 1995-06-01
BR9404781A (pt) 1995-08-01
EP0655249A1 (de) 1995-05-31
CN1108104A (zh) 1995-09-13
ZA949468B (en) 1995-08-01
DK0655249T3 (da) 2001-06-18
NZ270002A (en) 1997-05-26
DE59409670D1 (de) 2001-04-12
ES2154665T3 (es) 2001-04-16
AU7908694A (en) 1995-06-08
US6242424B1 (en) 2001-06-05
PT655249E (pt) 2001-08-30

Similar Documents

Publication Publication Date Title
FI940787A0 (fi) Annostusmuoto lääkkeen annostelemiseksi lyhyessä ajanjaksossa
NO306377B1 (no) Doseform for avgivelse av et medikament
IS1858B (is) Aðferð til að framleiða lyfjablöndu á formi smápilla til að meðhöndla þarmabólgur
KR950002785A (ko) 골량을 증가시키기 위한 부갑상선 호르몬 및 랄옥시펜
KR930702022A (ko) 인슐린의 경구 투여에 의한 타잎 1 당뇨병의 치료 또는 예방법
NO920740D0 (no) Doseringsform for oral administrering av hypoglykemisk glipizid
ATE71293T1 (de) Arzneiformulierung.
DK0724885T3 (da) Pernasal sammensætning og pernasalt præparat indeholdende dette
KR920702216A (ko) 아세틸 d-카르니틴의 녹내장 치료에의 용도
KR950013513A (ko) 약제 제조용 모에노마이신 및 이의 유도체, 및 모에노마이신 또는 이의 유도체를 함유하는 약제
KR880002515A (ko) 흡수 및 작용이 빠른 설린다크 또는 나트륨 설린다크와 염기의 혼합물
ES2188582T3 (es) El uso de ranitidina-citrato de bismuto en combinacion con claritromicina o claritromicina y tetraciclina en la fabricacion de un medicamento para tratar trastornos gastrointestinales.
ZA898667B (en) Use of acetyl l-carnitine in the therapeutic treatment of cataract and pharmaceutical compositions useful in such treatment
RU95101385A (ru) Продукты, содержащие g-csf и tnf связующие протеина
KR970061244A (ko) 치매 치료용 약학 조성물
KR910005858A (ko) 지방산 요법
AU8687391A (en) Lithium treatment
MX9203405A (es) Compuestos activos para usarse en el tratamiento de tumores.
KR920702225A (ko) 약학 조성물
DE3688787D1 (de) Herstellung eines arzneimittels gegen arthritis und rheumatismus.
KR900017599A (ko) 종양 치료용 약학 조성물
KR870005642A (ko) 디플루니살과 트로메타민의 혼합물
KR890001558A (ko) 공황(恐慌) 장애를 경감시키는 제피론 및 이의 약학적 허용 산부가염
IT1265224B1 (it) Composizioni farmaceutiche per uso orale per il trattamento delle manifestazioni ulcerose gastro-duodenali ed esofagee
BR9912765A (pt) Utilização de cloreto de sódio

Legal Events

Date Code Title Description
PA0109 Patent application

Patent event code: PA01091R01D

Comment text: Patent Application

Patent event date: 19941129

PG1501 Laying open of application
PC1203 Withdrawal of no request for examination
WITN Application deemed withdrawn, e.g. because no request for examination was filed or no examination fee was paid